| 2023年三季报 | 2023年中报 | 2022年年报 | 2022年三季报 | 2022年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| CMO/CDMO/CRO业务(元) | - | 15,081,874.07 | 64,608,862.41 | - | 27,631,505.25 |
| 海正药品(元) | - | 3,174,111,772.88 | 6,721,346,621.64 | - | 3,279,919,249.96 |
| 医药商业(元) | 3,903,000,000.00 | 2,739,633,925.35 | 4,914,597,032.73 | 3,682,306,500.00 | 2,319,284,839.90 |
| 医药生产(元) | 4,610,000,000.00 | - | - | 5,252,610,400.00 | - |
| 其他主营业务(元) | - | - | - | - | 4,031,601.41 |
| 其他业务(元) | - | - | - | - | 105,822,027.01 |
| 其他(元) | 188,000,000.00 | 2,650,660.98 | 7,994,863.41 | 5,991,500.00 | 4,031,601.41 |
| 营业成本(元) | |||||
| CMO/CDMO/CRO业务(元) | - | 6,167,072.05 | 28,719,807.55 | - | 4,547,864.47 |
| 海正药品(元) | - | 1,040,381,425.82 | 2,528,586,626.05 | - | 1,369,061,763.01 |
| 医药商业(元) | 3,385,000,000.00 | 2,380,938,176.15 | 4,214,502,835.75 | 3,087,127,000.00 | 1,963,486,867.06 |
| 医药生产(元) | 1,564,000,000.00 | - | - | 2,181,435,800.00 | - |
| 其他主营业务(元) | - | - | - | - | 4,409,034.44 |
| 其他业务(元) | - | - | - | - | 90,716,695.92 |
| 其他(元) | 158,000,000.00 | 2,259,853.13 | 7,789,061.16 | 2,918,200.00 | 4,409,034.44 |
| 毛利(元) | |||||
| CMO/CDMO/CRO业务(元) | - | 8,914,802.02 | 35,889,054.86 | - | 23,083,640.78 |
| 海正药品(元) | - | 2,133,730,347.06 | 4,192,759,995.59 | - | 1,910,857,486.95 |
| 医药商业(元) | 518,000,000.00 | 358,695,749.20 | 700,094,196.98 | 595,179,500.00 | 355,797,972.84 |
| 医药生产(元) | 3,046,000,000.00 | - | - | 3,071,174,600.00 | - |
| 其他主营业务(元) | - | - | - | - | -377,433.03 |
| 其他业务(元) | - | - | - | - | 15,105,331.09 |
| 其他(元) | 30,000,000.00 | 390,807.85 | 205,802.25 | 3,073,300.00 | -377,433.03 |
| 毛利率(%) | |||||
| CMO/CDMO/CRO业务(%) | - | 59.11 | 55.55 | - | 83.54 |
| 海正药品(%) | - | 67.22 | 62.38 | - | 58.26 |
| 医药商业(%) | 13.27 | 13.09 | 14.25 | 16.16 | 15.34 |
| 医药生产(%) | 66.07 | - | - | 58.47 | - |
| 其他主营业务(%) | - | - | - | - | -9.36 |
| 其他业务(%) | - | - | - | - | 14.27 |
| 其他(%) | 15.96 | 14.74 | 2.57 | 51.29 | -9.36 |
| 收入构成(%) | |||||
| CMO/CDMO/CRO业务(%) | - | 0.25 | 0.55 | - | 0.48 |
| 海正药品(%) | - | 53.51 | 57.41 | - | 57.13 |
| 医药商业(%) | 44.86 | 46.19 | 41.97 | 41.18 | 40.40 |
| 医药生产(%) | 52.98 | - | - | 58.75 | - |
| 其他主营业务(%) | - | - | - | - | 0.07 |
| 其他业务(%) | - | - | - | - | 1.84 |
| 其他(%) | 2.16 | 0.04 | 0.07 | 0.07 | 0.07 |
| 毛利构成(%) | |||||
| CMO/CDMO/CRO业务(%) | - | 0.36 | 0.73 | - | 1.00 |
| 海正药品(%) | - | 85.29 | 85.06 | - | 82.93 |
| 医药商业(%) | 14.41 | 14.34 | 14.20 | 16.22 | 15.44 |
| 医药生产(%) | 84.75 | - | - | 83.70 | - |
| 其他主营业务(%) | - | - | - | - | -0.02 |
| 其他业务(%) | - | - | - | - | 0.66 |
| 其他(%) | 0.83 | 0.02 | 0.00 | 0.08 | -0.02 |